Amjad Hameed
Not Available
Faiz Batool
Not Available
Tahira Iqbal
Not Available
Tayyba Tabassum Baig
Not Available
Javed Anver Qureshi
Not Available
ABSTRACT
This study was based on biodisposition kinetics of ofloxacin in Pakistani healthy female volunteers after oral administration. Ten healthy female volunteers were included in this study. The blood samples of each volunteer were collected after oral administration of ofloxacin. The concentration of ofloxacin in blood samples was measured by microbiological assay. The mean (SE) values of time to peak (tmax), peak concentration (Cmax), absorption half life (t1/2α), absorption rate constant (ka), elimination half life (t1/2), elimination rate constant (K10β), were 1.012 ± 0.176 h, 0.907 ± 0.126 μg ml-1, 0.516? 0.093h, 13.593?2.936L h-1, 2.996 ± 0.567h and 0.291 ± 0.693 L h-1 respectively. The mean (SE) values for area under curve (AUC), clearance (CL), volume of distribution (Vd) and mean resident time (MRT) were 4.358 ± 0.771 h.mg-1 1itter, 53.470 ± 11.068 l h-1, 214.41?49.127 litter and 5.030 ± 0.705 h respectively. Values of parameters like, volume of distribution, total body clearance and absorption rate constant were higher, while elimination half life, AUC, Cmax, and tmax were lower in local population as compared with foreign studies. There was no influence of body surface area on total body clearance of ofloxacin (R2=0.0581). There was an increase in body clearance of ofloxacin (R2=0.2236) and area under curve (AUC) for ofloxacin (R2=0.258) with increasing body surface are of volunteers. Therefore body surface area of volunteers may slightly influence the total body clearance and area under curve for ofloxacin. These gender-related differences mainly low body weight and surface area in females may warrant dosage adjustments.
PDF References Citation
How to cite this article
Amjad Hameed, Faiz Batool, Tahira Iqbal, Tayyba Tabassum Baig and Javed Anver Qureshi, 2002. Biodisposition Kinetics of Ofloxacin in Pakistani Healthy Female Volunteers after Oral Administration. Journal of Biological Sciences, 2: 775-779.
DOI: 10.3923/jbs.2002.775.779
URL: https://scialert.net/abstract/?doi=jbs.2002.775.779
DOI: 10.3923/jbs.2002.775.779
URL: https://scialert.net/abstract/?doi=jbs.2002.775.779
REFERENCES
- Corvaisier, S., N. Bleyzac, M. DeMontclos, M. Druguet, G. Aldrand, G. Carret and P. Maire, 1999. Renal fedifrential aging processes and ofloxacin pharmacokinetics in the elderly. Therapeutics, 54: 223-231.
PubMed - Guay, D., K. Track and S. Flor, 1991. Safety and Pharmacokinetics of single dose intravenous ofloxacin in healthy volunteers. Int. J. Clin. Parmacol. Res., 11: 203-209.
PubMedDirect Link - Guay, D.R., J.A. Opsahl, F.G. Mcmahom, R. Vargas, G.R. Matzke and S. Flor, 1992. Safety and pharmacokinetics of multiple doses of intravenous ofloxacin in healthy volunteers. Antimicrobial Agents Chemother., 36: 308-312.
Direct Link - Hameed, A., I. Tahira, N. Muhammad, B. Faiz, B. Tayyba Tabassum, A. Shafaqat and N. Farwa, 2002. Pharmacokinetics of ofloxacin in male volunteers following oral administration. Pak. J. Biol. Sci., 5: 1098-1100.
CrossRefDirect Link - LaCreta, F.P., G.D. Kollia, G. Duncan, D. Behr and D.M. Grasela, 2000. Age and gender effects on the pharmacokinetics of gatifloxacin. Pharmacotherapy, 20: 67S-75S.
Direct Link - Lamp, K.C., E.M. Bailey and M.J. Ryback, 1992. Ofloxacin clinical pharmacokinetics. Clin. Pharmacokinetics., 22: 32-46.
PubMed - Molinaro, M., P. Villani, M.B. Regazzi, R. Roundanelli and G. Doveri, 1992. Pharmacokinetics of ofloxacin in elderly patients and in healthy young subjects. Eur. J. Clin. Pharmacol., 43: 105-107.
CrossRefDirect Link - Nawaz, M., T. Iqbal and R. Nawaz, 1992. Oral disposition kinetics of ofloxacin in patients with compensated liver cirrhosis. Chemotherapy, 38: 1-6.
PubMed - Sowinski, K.M., S.R. Abel, W.R. Clark and B.A. Mueller, 1999. Effect of gender on the pharmacokinetics of ofloxacin. Pharmacotherapy, 19: 442-446.
PubMedDirect Link - Stein, G.E., M.L. Bel, S.C. Flor and M. Zinny, 1991. Bioavailability and pharmacokinetics of oral oflaxacin formulations in normal subjects. Curr. Med. Res. Opin., 12: 479-484.
Direct Link - Verho, M., V. Malerezyk, D. Damm and K.H. Lehr, 1996. Pharmacokinetics of levofloxacin in comparison to the racemic mixture of ofloxacin in man. Drug Metab. Drug Interact., 13: 57-67.
Direct Link - Yuen, G.J., G.L. Drusano, J. Brooks and S. Flor, 1992. Use of nonlinear, mixed-effects modeling for population analysis of ofloxacin: Effect of age on oral drug pharmacokinetics. Pharmacotherapy, 12: 88-92.
PubMedDirect Link - Yuk, J.H., C.H. Nightingale, R. Quintiliani and K.R. Sweeney, 1991. Bio-availability and pharmacokinetics of ofloxacin in healthy volunteers. Antimicrob. Agents Chemother., 35: 384-386.
Direct Link